Second prostate-specific membrane antigen PET scan can change treatment for nearly half of prostate cancer patients
A second PSMA PET scan is proven to alter treatment plans for nearly half of prostate cancer patients, according to new findings.
Velocity timeline
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
The brief
New data indicates that a second prostate-specific membrane antigen (PSMA) PET scan can lead to treatment changes for nearly half of prostate cancer patients. This trend highlights the clinical utility of repeated imaging in managing the disease.
Coverage from Radiology Business, Medical Xpress, and healthcare-in-europe.com emphasizes the benefit of the second scan. Additionally, Urology Times reports that the updated AUA/SUO Advanced Prostate Cancer guideline now emphasizes the role of PSMA-PET.
Future attention will likely focus on the implementation of these updated AUA/SUO guidelines in clinical practice.
Synthesized by Newsylist from the headlines below under a strict no-invention contract. ✓ fact-checked: all claims supported by sources Updated 15m ago.
Quick answers
How often does a second PSMA PET scan change treatment?
According to coverage, it can change treatment for nearly half of prostate cancer patients.
Which medical guidelines have been updated regarding this technology?
The AUA/SUO Advanced Prostate Cancer guideline has been updated to emphasize the role of PSMA-PET.
What does PSMA stand for in these scans?
PSMA stands for prostate-specific membrane antigen.
Coverage (4)
- 2nd PET scan changes treatment for nearly half of prostate cancer patients Radiology Business · 1d ago
- Treatment change for prostate cancer: study reveals benefit of second PSMA PET healthcare-in-europe.com · 1d ago
- Updated AUA/SUO Advanced Prostate Cancer guideline emphasizes role of PSMA-PET Urology Times · 1d ago
- Second prostate-specific membrane antigen PET scan can change treatment for nearly half of prostate cancer patients Medical Xpress · 1d ago broke it first
People, places & organizations
Topics
Related trends
Is testosterone replacement a fix for the blahs of aging?
A shift in government policy regarding testosterone therapy is sparking a debate over the treatment of age-related hormone decline.
New blood test detects 90% of aggressive prostate cancer cases, beating current screenings
A new blood test, Stockholm3, is outperforming traditional PSA screenings by detecting 90% of aggressive prostate cancer cases.
Thousands of men with prostate cancer will now be offered high-powered radiotherapy on the NHS
Thousands of men with prostate cancer can now access high-powered radiotherapy via the NHS to treat early-stage disease more efficiently.
Prostate cancer blood test detects twice as many cases
A new multicomponent blood test is outperforming traditional PSA screenings in detecting clinically significant prostate cancer.